E-mail this story

Lawmakers look to repeal Medicare provision aiding Amgen drug

A bipartisan group of U.S. lawmakers is seeking to repeal a Medicare-pricing provision in the recent "fiscal cliff" deal that benefits biotech giant Amgen Inc.

By Chad Terhune

January 24, 2013

Send to (as many as 3 e-mail addresses, separated by commas):

Send me a copy.

From:

200 characters remaining